Clinical trials
Completed Lymphoma, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
233 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2002 | 6 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 11 |
| 2006 | 9 |
| 2007 | 9 |
| 2008 | 10 |
| 2009 | 9 |
| 2010 | 10 |
| 2011 | 10 |
| 2012 | 8 |
| 2013 | 15 |
| 2014 | 9 |
| 2015 | 6 |
| 2016 | 16 |
| 2017 | 13 |
| 2018 | 14 |
| 2019 | 14 |
| 2020 | 18 |
| 2021 | 10 |
| 2022 | 7 |
| 2023 | 4 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 233 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 13 |
| M.D. Anderson Cancer Center | 10 |
| Pharmacyclics LLC. | 7 |
| Pfizer | 5 |
| Fred Hutchinson Cancer Center | 4 |
| Lymphoma Study Association | 4 |
| Mayo Clinic | 4 |
| Medical College of Wisconsin | 4 |
| Novartis Pharmaceuticals | 4 |
| Seagen Inc. | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 233 |
| Lymphoma, Non-Hodgkin | 62 |
| Lymphoma | 55 |
| Lymphoma, Follicular | 48 |
| Lymphoma, Large B-Cell, Diffuse | 46 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 38 |
| Lymphoma, Mantle-Cell | 33 |
| Recurrence | 27 |
| Lymphoma, B-Cell, Marginal Zone | 24 |
| Hodgkin Disease | 21 |
Trials
Showing 76 to 100 of 233. Each trial links to its page on Pharma Observatory.
133 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.